Filing Details

Accession Number:
0001567619-21-018515
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-21 08:47:14
Reporting Period:
2021-10-18
Accepted Time:
2021-10-21 08:47:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1815903 Petros Pharmaceuticals Inc. PTPI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208886 D John Shulman 1185 Avenue Of The Americas, 3Rd Floor
New York NY 10036
Yes No Yes No
1835386 Jcp Iii Sm Aiv, L.p. 1185 Avenue Of The Americas, 3Rd Floor
New York NY 10036
No No Yes No
1835421 Juggernaut Partners Iii Gp, L.p. 1185 Avenue Of The Americas, 3Rd Floor
New York NY 10036
No No Yes No
1835433 Juggernaut Partners Iii Gp, Ltd. 1185 Avenue Of The Americas, 3Rd Floor
New York NY 10036
No No Yes No
1836319 Metp Holdings Llc 1185 Avenue Of The Americas, 3Rd Floor
New York NY 10036
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2021-10-18 1,661,807 $1.72 5,057,771 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2021-10-18 1,661,807 $0.00 1,661,807 $1.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,661,807 2021-10-18 2026-10-18 No 4 P Indirect
Footnotes
  1. See Note (1) in Exhibit 99.1.
  2. Includes 185,414 shares of Common Stock previously held of record by Metuchen Therapeutics, LLC ("MT") that were received by JCP III SM AIV, L.P. as a liquidating distribution. In prior reports, the reporting persons beneficially owned the 185,414 previously held by MT.